Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 1,101–1,150 of 1,280 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06496308	Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment	recruiting	Phase 3	78	Ruijin HospitalOTHER	1	Jul 11, 2024	clinicaltrials
NCT06243393	Sacituzumab Govitecan in Metastatic Colorectal Cancer(TROPHIT1)	recruiting	Phase 2 / Phase 3	80	University Hospital HeidelbergOTHER	1	Jul 10, 2024	clinicaltrials